首页> 外文OA文献 >Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

【2h】

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

机译：灭活SARS-COV-2疫苗的安全性和免疫原性，BBIBP-CORV：随机，双盲，安慰剂控制，第1/2期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Shengli Xia; Yuntao Zhang; Yanxia Wang; Hui Wang; Yunkai Yang; George Fu Gao; Wenjie Tan; Guizhen Wu; Miao Xu; Zhiyong Lou; Weijin Huang; Wenbo Xu; Baoying Huang; Huijuan Wang; Wei Wang; Wei Zhang; Na Li; Zhiqiang Xie; Ling Ding; Wangyang You; Yuxiu Zhao; Xuqin Yang; Yang Liu; Qian Wang; Lili Huang; Yongli Yang; Guangxue Xu; Bojian Luo; Wenling Wang; Peipei Liu; Wanshen Guo; Xiaoming Yang;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials (vol 391, pg 563, 2018) [J] . Modjarrad Kayvon, Lin Leyi, George Sarah L., The Lancet . 2020,第10241期

机译：纯净的含有纯化的Zika病毒疫苗候选的三次试验的初步综合安全性和免疫原性结果：第1阶段，随机，双盲，安慰剂对照临床试验（Vol 391，PG 563,2018）
2. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials [J] . Modjarrad Kayvon, Lin Leyi, George Sarah L., The Lancet . 2018,第10120期

机译：纯净的综合安全性和免疫原性结果由纯化的止动Zika病毒疫苗候选的三次试验结果：第1阶段，随机，双盲，安慰剂对照临床试验
3. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial [J] . Nature reviews Cancer . 2020,第2期

机译：口服，灭活，肠毒素大肠杆菌的安全性和免疫原性，在孟加拉国儿童和婴儿的eTvax：双盲，随机，安慰剂控制阶段1/2试验
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. A randomized double-blind placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated Vero cell): a structured summary of a study protocol for a randomised controlled trial [O] . Murat Akova, Serhat Unal 2021

机译：随机双盲安慰剂对照期III临床试验评价SARS-COV-2疫苗（灭活VERO细胞）的功效和安全性：随机对照试验的研究方案的结构性概述
7. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial [O] . Zhiwei Wu, Yaling Hu, Miao Xu, 2021

机译：60岁及以上健康成人的灭活SARS-COV-2疫苗（Coronavac）的安全性，耐受性和免疫原性：随机，双盲，安慰剂控制，第1/2期临床试验

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

著录项

相似文献

相关主题

期刊订阅